Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia
Journal of Cardiovascular Electrophysiology · 2024
DOI: 10.1111/jce.16432 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von John Sullivan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Tachycardia, Supraventricular, Calcium Channel Blockers, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Introduction
Supraventricular tachycardia (SVT) is a common pediatric arrhythmia. Beta blockers (BBs) and calcium channel blockers (CCBs) are used for treatment despite little data examining their use. We describe the prescriptive tendencies, efficacy, and tolerability of BBs and CCBs used in the treatment of pediatric SVT. Methods and Results This is a multicenter retrospective cohort study from three academic children's hospitals. Individuals aged 1–21 years at time of SVT diagnosis initiated on a BB or a CCB between 01/01/2010 and 12/31/2020 were included. Exclusion criteria were pre‐excitation, ectopic atrial tachycardia, and hemodynamically significant heart disease. Demographic, comorbidity, symptomatology, and medication data were collected. Treatment success was defined using a composite data abstraction tool. Of 164 patients, 151 received a BB and 13 received a CCB. The success rate on the initial dosage was 46% for both BB and CCB; the success rate following dosage adjustments was also comparable for BBs (98/151, 65%) and CCBs (9/13, 69%). While 27 (18%) BB patients experienced intolerable side effects, no CCB patient did.
Conclusion
Treatment with a BB or CCB was successful in half of patients. BBs were prescribed more frequently than CCBs but were associated with more side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, Connecticut, USA.
- Department of Pediatrics, Division of Pediatric Cardiology, Washington University in St. Louis, St. Louis, Missouri, USA.
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Division of Cardiology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pediatrics, Division of Cardiology, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: John Sullivan
Zitieren
APA
Sullivan, J., Pompa, A. G., Schieber, J., Arora, G., Dionne, A., & Beach, C. (2024). Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16432
Vancouver
Sullivan J, Pompa AG, Schieber J, Arora G, Dionne A, Beach C. Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16432
BibTeX
@article{Sullivan2024,
author = {Sullivan, John and Pompa, Anthony G and Schieber, Jonah and Arora, Gaurav and Dionne, Audrey and Beach, Cheyenne},
title = {Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2024},
doi = {10.1111/jce.16432}
}
EUVIMED